Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells

Yue Xiaohan, Kang Quan, Shi Yulu, Luo Qing

PDF(6995 KB)
PDF(6995 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (08) : 949-958. DOI: 10.13406/j.cnki.cyxb.003560
Basic research

Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells

Author information +
History +

Abstract

Objective To investigate the regulatory effect of sirtuin 4 （SIRT4） overexpression on the malignant biological behavior of human osteosarcoma cells and osteogenic differentiation，as well as the influence of SIRT4 overexpression on mitochondrial energy metabolism. Methods U2OS and MG63 osteosarcoma cell lines with stable overexpression of SIRT4 were constructed，and qRT-PCR and Western blot were used to measure the mRNA and protein expression levels of SIRT4；CCK-8 assay，colony formation assay，and EDU555 staining were used to observe cell proliferation；tibial tumorigenesis assay in nude mice was used to observe tumorigenic ability；flow cytometry was used to detect cell cycle；DAPI staining and Annexin V-APC/7-AAd double staining were used to measure cell apoptosis；wound healing assay and Transwell assay were used to observe the migration and invasion abilities of cells；alkaline phosphatase（ALP） staining and alizarin red S staining were used to detect early and late osteogenic differentiation，respectively；glucose assay kit was used to determine the content of glucose in the medium and cells；lactic acid assay kit was used to determine the content of lactic acid in the medium and cells；triphosphate assay kit was used to determine the total content of adenosine triphosphate（ATP） in the medium and cells；tetramethylrhodamine ethyl ester perchlorate staining was used to measure mitochondrial membrane potential. Results The SIRT4 overexpression group had significant reductions in the proliferation，migration，and invasion abilities of cells，a significant reduction in the tumor volume of tibial osteoblastoma in nude mice，and a significant increase in apoptotic cells. As for cell cycle，the SIRT4 overexpression group showed a significant increase in the proportion of cells in G0/G1 phase and a significant reduction in the proportion of cells in S phase. ALP staining and alizarin red S staining showed a significant increase in the number of calcium salt nodules in the SIRT4 overexpression group. Compared with the control group，the SIRT4 overexpression group had significant reductions in the consumption of glucose in the medium and the content of glucose in cells，as well as significant reductions in the content of lactic acid in cells and the medium. The SIRT4 overexpression group had a lower mitochondrial membrane potential than the control group. Conclusion In U2O and MG63 cells，SIRT4 overexpression inhibits the proliferation，migration，invasion，and tumorigenic ability of osteosarcoma cells，promotes the apoptosis of osteosarcoma cells and early and late osteogenic differentiation，and regulates energy metabolism in osteosarcoma cells.

Key words

osteosarcoma / sirtuin 4 / malignant biological behavior / osteogenic differentiation / energy metabolism

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
Yue Xiaohan , Kang Quan , Shi Yulu , et al. Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells. Journal of Chongqing Medical University. 2024, 49(08): 949-958 https://doi.org/10.13406/j.cnki.cyxb.003560

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis
1
Cho WH， Song WS， Jeon DG，et al. Differential presentations，clinical courses，and survivals of osteosarcomas of the proximal humerus over other extremity locations[J]. Ann Surg Oncol，2010，17（3）：702-708．
本文引用 [1]
2
Cole S， Gianferante DM， Zhu B，et al. Osteosarcoma：a Surveillance，Epidemiology，and End Results program-based analysis from 1975 to 2017[J]. Cancer，2022，128（11）：2107-2118．
本文引用 [1]
3
Hanahan D， Weinberg RA. Hallmarks of cancer：the next generation[J]．Cell，2011，144（5）：646-674．
本文引用 [1]
4
Zhu YM， Yan YF， Principe DR，et al. SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis[J]. Cancer Metab，2014，2：15．
本文引用 [1]
5
Haigis MC， Mostoslavsky R， Haigis KM，et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells[J]. Cell，2006，126（5）：941-954．
本文引用 [2]
6
Laurent G， German NJ， Saha AK，et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase[J]. Mol Cell，2013，50（5）：686-698．
本文引用 [1]
7
Huang GY， Cheng J， Yu FD，et al. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer[J]. Oncol Rep，2016，35（5）：2801-2810．
本文引用 [1]
8
Jeong SM， Xiao CY， Finley LW，et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism[J]. Cancer Cell，2013，23（4）：450-463．
本文引用 [1]
9
Wan W， Li YN， Zhou CY，et al. SIRT4 expression in laryngeal squamous cell carcinoma[J]. Pharmazie，2020，75（12）：646-650．
本文引用 [1]
10
Jeong SM， Lee AN， Lee J，et al. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma[J]. J Biol Chem，2014，289（7）：4135-4144．
本文引用 [2]
11
Cai GH， Ge ZH， Xu YQ，et al. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism[J]. Sci Rep，2022，12（1）：12208．
本文引用 [2]
12
Zhu YY， Wang GY， Li XB，et al. Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells[J]. Oncol Lett，2018，16（2）：1675-1681．
本文引用 [1]
13
Xing JL， Li J， Fu L，et al. SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway[J]. Cancer Med，2019，8（16）：7086-7097．
本文引用 [1]
14
Delgrosso E， Scocozza F， Cansolino L，et al. 3D bioprinted osteosarcoma model for experimental boron neutron capture therapy （BNCT） applications：preliminary assessment[J]. J Biomed Mater Res B Appl Biomater，2023，111（8）：1571-1580．
本文引用 [1]
15
Brown HK， Schiavone K， Gouin F，et al. Biology of bone sarcomas and new therapeuticdevelopments[J]. Calcif Tissue Int，2018，102（2）：174-195．
本文引用 [1]
16
Dong ZH， Liao ZP， He YL，et al. Advances in the biological functions and mechanisms of miRNAs in the development of osteosarcoma[J]. Technol Cancer Res Treat，2022，21：15330338221117386．
17
Xie DL， Wang ZQ， Li J，et al. Targeted delivery of chemotherapeutic agents for osteosarcoma treatment[J]. Front Oncol，2022，12：843345．
本文引用 [1]
18
Panez-Toro I， Muñoz-García J， Vargas-Franco JW，et al. Advances in osteosarcoma[J]. Curr Osteoporos Rep，2023，21（4）：330-343．
本文引用 [1]
19
Huang H， Han Y， Chen ZJ，et al. ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β-catenin signalling pathways[J]. J Cell Mol Med，2020，24（10）：5652-5664．
本文引用 [1]
20
Zhu WT， Zeng XF， Yang H，et al. Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2/STAT3 pathway[J]. Int J Nanomed，2023，18： 2677-2691.
本文引用 [1]
21
Wu W， Zhang ZH， Jing DD，et al. SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma[J]. Cell Death Dis，2022，13（6）：523．
本文引用 [1]
22
Zhao S， Wang JM， Yan J，et al. BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase[J]. Cell Death Dis，2019，10（4）：284．
本文引用 [1]
23
Yalçın GD， Colak M. SIRT4 prevents excitotoxicity via modulating glutamate metabolism in glioma cells[J]. Hum Exp Toxicol，2020，39（7）：938-947．
24
Cui Y， Bai YB， Yang JN，et al. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway[J]. Carcinogenesis，2021，42（3）：481-492．
本文引用 [1]
25
Hu QS， Qin Y， Ji SR，et al. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer[J]. Cancer Lett，2019，452：226-236．
本文引用 [1]
26
Ping DN， Pu XF， Ding GP，et al. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex[J]. Biochim Biophys Acta Gene Regul Mech，2023，1866（2）：194941．
27
Wang YM， Guo YM， Gao JZ，et al. Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage[J]. Cancer Manag Res，2018，10：5591-5603．
本文引用 [1]
28
仇　超，康　权，迭小红，等. Id1基因对人骨肉瘤细胞恶性逆转向成骨分化的影响[J]. 第三军医大学学报，2016，38（4）：344-349．
Qiu C， Kang Q， Die XH，et al. Effect of Id1 gene on reversing malignant biological behaviors and inducing osteogenic differentiation of human osteosarcoma cells[J]. J Third Mil Med Univ，2016，38（4）：344-349．
本文引用 [1]
29
Roschger C， Cabrele C. The Id-protein family in developmental and cancer-associated pathways[J]. Cell Commun Signal，2017，15（1）：7.
本文引用 [1]
30
Singh SK， Singh S， Gadomski S，et al. Id1 ablation protects hematopoietic stem cells from stress-induced exhaustion and aging[J]. Cell Stem Cell，2018，23（2）：252-265.
本文引用 [1]
31
Lin ZK， Liu Y， Xu T，et al. STAT3-mediated promoter-enhancer interaction up-regulates inhibitor of DNA binding 1（ID1） to promote colon cancer progression[J]. Int J Mol Sci，2023，24（12）：10041．
本文引用 [1]
32
Sharma BK， Kolhe R， Black SM，et al. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells[J]. FASEB J，2016，30（1）：262-275．
本文引用 [1]
33
Xu X， Hou YQ， Lin SM，et al. Sodium selenite inhibits proliferation of lung cancer cells by inhibiting NF-κB nuclear translocation and down-regulating PDK1 expression which is a key enzyme in energy metabolism expression[J]. J Trace Elem Med Biol，2023，78：127147．
本文引用 [1]
34
Xing BY， Shen CY， Yang QL，et al. miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1[J]. Int J Exp Pathol，2023，104（3）：117-127．
本文引用 [1]
35
Kimura K， Chun JH， Lin YL，et al. Tetra-O-methyl-nordihy-droguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets[J]. PLoS One，2023，18（5）：e0285536．
本文引用 [1]
36
Weng YP， Duan WH， Yu XC，et al. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis[J]. Cancer Sci，2023，114（6）：2345-2359．
本文引用 [1]
37
Mathias RA， Greco TM， Oberstein A，et al. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity[J]. Cell，2014，159（7）：1615-1625．
本文引用 [1]

Comments

PDF(6995 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Journal of Chongqing Medical University, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉